Thomson Medical confirms discussions about potential deal
Chong Xin Wei
DeeperDive is a beta AI feature. Refer to full articles for the facts.
THOMSON Medical Group , a Singapore-based healthcare company, confirmed discussions about a potential transaction on Thursday (Jun 8) after reports said that it is in advanced talks to purchase a controlling stake in Vietnam’s FV Hospital.
The healthcare company – backed by tycoon Peter Lim – had surpassed other interested candidates to remain in the bidding and is working with a financial adviser on the potential acquisition.
In 2022, Bloomberg reported that Quadria Capital, a healthcare-focused private equity firm, was exploring a sale of its stake in FV Hospital. The sale could fetch around US$300 million to US$400 million.
It also noted that Quadria and Thomson Medical could still decide against a transaction.
Separately, the group said it was in “preliminary confidential discussions to explore a potential transaction” but a definitive agreement had yet to be reached.
Shares of Thomson Medical Group closed flat at S$0.059 on Thursday, before the news.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
Middle East-linked energy supply shocks put Asean Power Grid back in focus
Beijing’s calculated silence on the Iran war
DPM Gan warns of 3 structural shifts to the global system that will bring greater challenges – and opportunities